In cancer immunotherapy, robust and efficient activation of cytotoxic CD8+ T cell immune responses is a promising, but challenging task. Dendritic cells (DCs) are well-known professional antigen ...

To determine whether virus-induced accelerated graft rejection was a result of antigen-specific immunity ... in which skin from mice expressing a defined tumor CTL epitope as a transgene was ...

Find out more about chemokines and their role in inducing immune response against different diseases, particularly cancer. News & Perspective Drugs & Diseases ...

Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

In the field of cancer immunotherapy, unconventional T cells (UCTs) and Chimeric Antigen Receptor (CAR) T cells have emerged as promising areas of research ...

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells Eric J. Small , Paige Fratesi , David M. Reese , George Strang , Reiner Laus , Madhusudan V. Peshwa , Frank H.

Background: CA 15.3 is a conventional TM commonly elevated in HR (+) /HER2 (-) ABC at diagnosis and is associated with a high burden of disease and shorter OS during follow-up for response to ...

The HLA Typing Market size is projected to be valued at USD 1,097.9 million in 2023 and reach USD 1.7 billion by ...

Circulating lymphocytes are also exposed to foreign antigen within the graft, where Kupffer cells act as antigen-presenting cells. Acute liver rejection occurs as early as 7 to 10 days after OLT.

The inquest concluded that there were several contributing factors to her death, including the failed stem cell transplant.

Minerva Biotechnologies - Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells Business Wire ...